It's a decision no woman wants to have to make, but new research shows that young breast cancer patients with high-risk genes ...

New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...

The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients ...